SAVSU Technologies unveils special shipping container for Ebola vaccine

SAVSU Technologies has developed a specialized shipping container for Ebola vaccines.
SAVSU Technologies has developed a specialized shipping container for Ebola vaccines. | Courtesy of

SAVSU Technologies, based in Santa Fe, New Mexico, said Tuesday it has created a specialized, high performance, small volume vaccine shipping container called CryoQ to safely transport temperature-sensitive vaccines through hot environments that do not have access to reliable refrigeration.

CryoQ trials show that it is capable of consistently maintaining a temperature of 70 degrees below zero C, which is necessary for transporting Ebola vaccine candidates to regions affected by the Ebola outbreak.

SAVSU participated in the World Health Organization (WHO) TechNet 21 Immunization Conference in 2013 as well as the conference for 2015 in Bangkok. SAVSU representatives discussed the need for a vaccine transportation container with officials from the WHO.

"A critical component of a successful clinical trial is to minimize variables. Maintaining a temperature of 94 degrees (bekow zero) F (70 degrees below zero C) during distribution in rural Africa is an enormous challenge; failure to do so can represent an unacceptable variable," SAVSU Technologies President Bruce McCormick said.

"Our mission is to close the gap from origin to patient in vaccine delivery, whether it is an Ebola vaccine, a biopharma product or any other critical material that improves global health,” McCormick said. “The Ebola epidemic really highlights that developing vaccines isn't enough, we need to safely deliver them."

Organizations in this Story

SAVSU Technologies

Want to get notified whenever we write about SAVSU Technologies ?
Next time we write about SAVSU Technologies, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.